Science Pool

Metabolic Characterization of a Perfusion Bioprocess

Posted by Evotec on Jun 14, 2024 3:27:12 PM

Biologics manufacturing typically uses engineered Chinese Hamster Ovary (CHO) cells to produce folded and glycosylated antibodies. Determining the optimum conditions to grow and maintain cell culture often requires considerable time and effort.

A quantitative understanding of cell metabolism through an analysis of cell culture metabolites can enable optimization growth conditions for improved titles or increased perfusion duration. Mass spectrometry is the optimum tool for metabolite measurement, however, transforming raw data into accurate quantitative measurement requires both expertise and extensive sample preparation.

In this poster we demonstrate the ability of simple sample preparation using universal calibrators and a novel machine learning algorithm to rapidly provide biological insight into bioprocessing samples taken from perfusion cell cultures.

Download our poster

Tags: Oncology, Posters, Formulation & CMC, Biologics, Immunology & Inflammation, Rare Diseases, Sample Management

The Downstream Data Browser

Posted by Evotec on Jun 5, 2024 4:37:18 PM

High-throughput screening methodologies have accelerated downstream development for monoclonal antibodies by enabling parallelized evaluation of chromatographic resins across a range of conditions. However, scientists must now interpret results in a meaningful and consistent way.

Learn how Just - Evotec Biologics' Downstream Data Browser automates visualization of high-throughput datasets, fits response surface statistical models, standardizes report results from a high-throughput screening method and facilitates comparison across molecules allowing the accelerated development of continuous biomanufacturing processes.

Read our poster to learn more

Tags: Neuroscience, Respiratory, Oncology, Kidney diseases, Women's health, Posters, Formulation & CMC, Biologics, Age-Related Diseases, IND Enabling Studies/Preclinical Development, Anti-Infectives, Immunology & Inflammation, Metabolic Disease & Complications, Rare Diseases

Establishing a New High Throughput Endocrine Disruptor Screening Panel

Posted by Evotec on Apr 4, 2024 4:06:50 PM

Endocrine disruptors, which can be either natural or man-made, interfere with the normal actions of hormones in the body. This can result in serious health issues such as cancer, birth defects and developmental disorders. Low cost screening models are needed to flag chemicals as potential endocrine disruptors at an early stage.

In this poster, we focus on:

  • the development of a new high throughput screening panel for chemicals to detect potential endocrine disruptors
  • the comparison between endocrine receptor activation assays expressing the human androgen receptor, the human estrogen receptor or the human thyroid receptor, and hormone receptor competitor binding assays using fluorescence polarisation.
  • the relationship between the literature and the data generated in the assays.

Read our poster to learn more about our research!

LEARN MORE

 

Tags: Posters, Toxicology & Safety

Development of a SP-TFF Step for Continuous End-to-End mAb Bioprocessing

Posted by Evotec on Apr 4, 2024 11:09:38 AM

Enhancing Single-Pass TFF for Antibody Therapeutics Manufacturing

Single-Pass Tangential Flow Filtration (TFF) plays a pivotal role in enabling fully end-to-end continuous manufacturing of antibody therapeutics. In this poster, we delve into the study of two distinct SP-TFF membrane configurations to determine which one is most effective for clinical and commercial production.

Key Findings:

1.    Concentration Factor Achievement: Both tested configurations successfully achieved the required concentration factor without encountering fouling issues.
2.    Shear Forces Mitigation: Neither setup generated significant shear forces that could harm the antibody product.
3.    Operational Success at Low Feed Flux: Both configurations demonstrated successful operations even under low feed flux conditions, reinforcing their suitability for large-scale manufacturing.

Future Directions: Our team of scientists and engineers will continue their investigation, exploring various load challenges, system perturbations, and methods for in-line concentration measurements. These efforts aim to enhance the robustness and efficiency of our manufacturing processes.


Download the Poster

Tags: Posters, Formulation & CMC, Biologics, Clinical Development

New Genotoxicity Pre-screening Package for Food Additives

Posted by Evotec on Apr 2, 2024 12:22:37 PM

Food additive testing is essential to ensure human safety during consumption. Early stage genotoxicity screening is an efficient way of triaging additives to ensure only the safest additives are taken forward for more rigorous testing.

In this poster, we focus on:

  • the development and validation of a new early stage genotoxicity approach for food additives
  • the use of a panel of in vitro assays for detecting clastogens (pH2AX) and aneugens (pH3) as well as micronuclei formation (MNT)

Read our poster to learn more about our research!

LEARN MORE

 

Tags: Posters, Toxicology & Safety

Toxicogenomics and AI: A Breakthrough in DILI Prediction

Posted by Evotec on Mar 27, 2024 12:49:09 PM

Prediction of drug-induced liver injury (DILI) is challenging. Translation from animals to humans is poor and manifestation of DILI can be complex mechanistically. 

In this poster, we focus on:

  • transcriptomics analysis of 128 compounds form the FDA Liver Toxicity Knowledge Base (68 associated with DILI and 60 not associated with DILI)
  • the use of machine learning in accurately predicting DILI and providing an insight into the mechanism of toxicity

Read our poster to learn more about our research!

LEARN MORE

 

Tags: Posters, Toxicology & Safety, Modelling and Simulation

Implementation of SplintR ligation qPCR as novel bioanalytical method for tissues quantification of oligonucleotide therapeutics for the expansion of the Evotec oligonucleotide drug discovery platform

Posted by Evotec on Feb 8, 2024 8:55:24 AM

 

Evotec possesses a comprehensive drug discovery platform to support oligonucleotide-based drug discovery from in silico design to clinical translation. Oligonucleotides therapeutics have been emerging as novel therapeutic modality for a vast range of diseases constantly growing resulting in 15 drugs currently approved. Here, we show our ongoing effort to further expand this platform by employing the recently developed splintR-qPCR as a novel bio-analytical method for quantification of oligonucleotides in tissues and comparing it to LC/MS and bDNA in use in Evotec. Within an Evotec internal R&D proof of concept study, the splintR-qPCR was proven as valid and comparable method to bDNA and gold-standard LC/MS. The high sensitivity, throughput and low costs compared to LC/MS and bDNA assay place splintR-qPCR as pivotal method that will strengthen Evotec oligonucleotides expertise on PKPD modelling.

Download our poster here!

Tags: Posters, In vivo Pharmacology

A DoE Approach to Study the Influence of TSWG Process Parameters on the Characteristics of Granules and Tablets

Posted by Evotec on Jan 17, 2024 3:02:27 PM

The Twin Screw Wet Granulation (TSWG) is a manufacturing process gaining increased attention in the pharmaceutical industry due to its versatility, scalable nature, and seamless integration into continuous manufacturing lines. Especially advantageous in early pharmaceutical development, where API quantity is limited, TSWG accommodates small batch sizes, facilitating later large-scale campaigns using the same equipment. 
A DoE study was conducted in order to assess the influence of the main process parameters on the characteristics of granules and tablets. A leading formulation containing a soluble drug, namely Niacin, was used, and the factors evaluated in the DoE were the screw design, the screw speed, the Liquid/Solid ratio (L/S), the feed rate and the screen type. 
The responses evaluated were referring to the process (e.g. torque), the granules (e.g. particle size distribution (PSD), density and flowability) and the tablets (e.g. tensile strength, friability and disintegration time). This study provides critical insights into optimizing TSWG processes, ensuring efficient granule and tablet outcomes.

Download the poster, which was presented at AAPS PharmSci360 2023, for comprehensive details on the influential process parameters and their impact on granulation and tablet characteristics in TSWG.

Download Now

Tags: Posters, Formulation & CMC, IND Enabling Studies/Preclinical Development

Characterization of Compression Behavior of Co-Processed Excipient for Production of Orally Dispersable Tablets and of their Blends with Active Ingredient

Posted by Evotec on Jan 17, 2024 2:57:58 PM

This text underscores the significance of Orally Dispersible Tablets (ODTs) for enhancing treatment compliance, particularly for patients with swallowing difficulties. Co-processed excipients for fast-disintegrating tablets (CPE-ODT) offer a convenient solution, combining a soluble filler and superdisintegrant. These can be efficiently blended with active ingredients, lubricants, and compressed into tablets, streamlining the development process. Investigating the relationships among compaction stress, compact solid fraction, and mechanical strength is crucial for optimizing tablet composition and speeding up development. Striking a balance between inter-particle bonding strength and porosity is especially vital for ODTs, ensuring rapid disintegration with sufficient mechanical resistance for downstream processes. The study aims to establish a general pre-formulation screening method by generating compressibility, compactibility, and tablettability profiles of CPE-ODTs blended with varying drug amounts. These data offer valuable insights into the impact of drug load on compression behavior and key properties, such as friability and disintegration time, facilitating the efficient development of ODTs.

Download this poster presented at AAPS PharmSci360 2023 for comprehensive details on this formulation screening approach.

Download Now

Tags: Posters, Formulation & CMC, IND Enabling Studies/Preclinical Development

A Study to Assess the Gastro-Resistance and Dissolution Rate of Enteric Coated Not-Banded Gelatin and HPMC Capsules

Posted by Evotec on Jan 17, 2024 2:52:52 PM

This poster discusses the development of oral enteric dosage forms as a solution to bypass the acidic stomach environment. Coated hard-shell capsules are more time and cost-efficient in early pharmaceutical development than enteric tablets and pellets. The current study assesses acid-resistance and dissolution rate of not-banded gelatin and HPMC capsules, filled at two weights, and coated with an enteric polymer at four levels. The goal is to determine the minimum enteric polymer needed for gastro-resistance, compare gelatin and HPMC shells in the coating process, and examine the impact of filling level and curing step on dissolution profiles, with fixed coating parameters. This research is important for optimizing the coating process and advancing the understanding of factors influencing gastro-resistance in oral enteric dosage forms.

Download our poster presented at AAPS PharmSci360 2023 for in-depth insights into this critical aspect of pharmaceutical development.

Feel free to make questions to our experts!press

 

Download the Poster Now

Tags: Posters, Formulation & CMC, IND Enabling Studies/Preclinical Development